🇺🇸 FDA
Patent

US 7872000

Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

granted A61KA61K31/395A61K31/519

Quick answer

US patent 7872000 (Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K31/395, A61K31/519, A61P, A61P13/12